Table 1.
Characteristics of participants
| Medulloblastoma patients | Healthy volunteers | |
|---|---|---|
| Total number | 42 | 52 |
| Male | 25 | 31 |
| Female | 17 | 21 |
| Baseline age (years) | ||
| Median | 10 | 12 |
| Range | 6 – 20 | 6 – 24 |
| Risk classification | ||
| Average-risk group | 32 | – |
| High-risk group | 10 | – |
| Radiation treatment | ||
| Craniospinal irradiation (Gy) | 23.4 – 39.6 | – |
| Boost to primary site (Gy) | 16.2 – 32.4 | – |
| Total dose to primary site (Gy) | 55.8 | |
| Chemotherapy | 4 cycles of high-dose cyclophosphamide, cisplatin, and vincristine | – |
| Extent of resection | – | |
| Gross total resection | 37 | – |
| Near total resection (>90%) | 5 | – |